Consent to the Distribution of New Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the new medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Glycerine 69.7% w/w in 1g, 2g and 4g Suppositories Daniels Pharmaceuticals Limited, Derby, England Iomeprol 30.62% w/v containing 150 mg iodine per ml Solution for injection Bracco Industria Chimica S.p.A., Milano, Italy Iomeron 150 Iomeprol 40.82% w/v containing 200 mg iodine per ml Solution for injection Bracco Industria Chimica S.p.A., Milano, Italy Iomeron 200 Iomeprol 51.03% w/v containing 250 mg iodine per ml Solution for injection Bracco Industria Chimica S.p.A., Milano, Italy Iomeron 250 Iomeprol 61.24% w/v containing 300 mg iodine per ml Solution for injection Bracco Industria Chimica S.p.A., Milano, Italy Iomeron 300 Iomeprol 71.44% w/v containing 350 mg iodine per ml Solution for injection Bracco Industria Chimica S.p.A., Milano, Italy Iomeron 350 Iomeprol 81.65% w/v containing 400 mg iodine per ml Solution for injection Bracco Industria Chimica S.p.A., Milano, Italy Iomeron 400 Thymol 0.016 mg, menthol 3.28 mg, eucalyptol 0.451 mg, guaiacol 0.016 mg, terpinol 0.016 mg Note: This replaces the entry in the notice published in the New Zealand Gazette, 29 April 1993, No. 58, page 1088, notice number 3436. Lozenge (eucalyptus and menthol, and lemon flavours) Laboratoires Thelfar, Pont des Charrettes, Uzes, France Valda Pastilles Tiaprofenic acid 300 mg Suppository Roussell SA, Brussell, Belgium Surgam Dated this 2nd day of June 1994. C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1991.